BD-413.jpg

epitope specific ab

case studies

 
 

Published example: Computationally designed epitope specific Multibody binding a cryptic epitope

  • Challenge: Designing an Ab for a cryptic epitope - not exposed to solvent in the native conformation*

  • N terminus covers epitope in the native conformation and desired binding site (epitope) is hidden

  • Biolojic’s solution - epitope specific Antibody which moves the N terminus and binds at the desired site, leading to the desired biological effect

Published in: Computational design of epitope specific functional antibodies, Cell Reports, Nov 2018

 
 
Capture IL!7.PNG
 

Crystal structure of Biolojic’s Antibody and binding site

 
 

Designed agonist for autoimmune diseases, developed in partnership with Nektar

“Biolojic […] announced that it has entered into a research collaboration and license option agreement with Nektar Therapeutics to discover and develop agonistic antibodies that activate a novel and previously un-drugged target for the treatment of autoimmune disease.”

Nektar deal announcement

 
NEKTAR LOGO.png
 
 

AULOS - Conditional agonist / antagonist for IO

“[Aulos] lead antibody candidate AU-007 binds endogenous IL-2 in such a way as to physically block the ability of IL-2 to bind with the α-chain on regulatory T cells. This approach may also make the most of a complex IL-2 feedback cycle.”

Nature’s review of current IL2 therapies in development